| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| ILLUMINA, INC. | Director | Common Stock | 18.3K | $2.11M | $115.01 | May 16, 2024 | Direct |
| VERACYTE, INC. | Director | Common Stock | 44.6K | $1.71M | $38.32 | Nov 12, 2024 | Direct |
| VERACYTE, INC. | Director | Stock Option (right to buy) | 20K | $264K | $13.19 | Nov 12, 2024 | Direct |
| FATE THERAPEUTICS INC | Director | Stock Option (Right to Buy) | 40K | $109K | $2.73 | Jun 7, 2024 | Direct |
| ILLUMINA, INC. | Director | Non-qualified Stock Option (Right to Buy) | 0 | May 25, 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| VCYT | VERACYTE, INC. | Nov 12, 2024 | 3 | -$454K | 4 | Nov 14, 2024 | Director |
| VCYT | VERACYTE, INC. | Jun 13, 2024 | 1 | $0 | 4 | Jun 17, 2024 | Director |
| FATE | FATE THERAPEUTICS INC | Jun 7, 2024 | 1 | $0 | 4 | Jun 11, 2024 | Director |
| ILMN | ILLUMINA, INC. | May 15, 2024 | 2 | -$70.4K | 4 | May 17, 2024 | Director |
| VCYT | VERACYTE, INC. | Jun 9, 2023 | 1 | $0 | 4 | Jun 13, 2023 | Director |
| FATE | FATE THERAPEUTICS INC | Jun 6, 2023 | 1 | $0 | 4 | Jun 7, 2023 | Director |
| ILMN | ILLUMINA, INC. | May 26, 2023 | 1 | $0 | 4 | May 31, 2023 | Director |
| ILMN | ILLUMINA, INC. | May 24, 2023 | 3 | $436K | 4 | May 25, 2023 | Director |
| VCYT | VERACYTE, INC. | Jun 16, 2022 | 1 | $0 | 4 | Jun 16, 2022 | Director |
| ILMN | ILLUMINA, INC. | May 26, 2022 | 1 | $0 | 4 | May 27, 2022 | Director |
| FATE | FATE THERAPEUTICS INC | Jun 9, 2021 | 2 | $0 | 4 | Jun 13, 2022 | Director |
| VCYT | VERACYTE, INC. | Jun 8, 2021 | 1 | $0 | 4 | Jun 10, 2021 | Director |
| FATE | FATE THERAPEUTICS INC | Jun 2, 2021 | 2 | $0 | 4 | Jun 4, 2021 | Director |
| ILMN | ILLUMINA, INC. | May 25, 2021 | 2 | -$153K | 4 | May 27, 2021 | Director |